4th JAK Inhibitors Drug Development Summit

The 4th JAK Inhibitors Drug Development Summit is dedicated to new JAK inhibitor therapeutics for dermatologic, autoimmune, oncologic and other inflammatory indications.

The 4th JAK Inhibitors Drug Development Summit covers topics such as:

• Current & Future State of the JAK Inhibitor Landscape
• JAK Inhibitor Formulation & Drug Delivery Systems
• How to Measure JAK Safety Against Practicality - Weighing the Benefit-Risk
• JAK Selectivity in the Push Towards Precise Medical Approaches
• Future Horizons: Best Prepare Your JAK Inhibitor Pipelines

The 4th JAK Inhibitors Drug Development Summit brings together senior attendees from pharma, biotech and academia.